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Abstract
 
The malignant Hodgkin and Reed-Sternberg cells of Hodgkin’s lymphoma (HL) and HL-
derived B cell lines were previously shown to be resistant to different apoptotic stimuli. We
show here that cytochrome 
 
c
 
 fails to stimulate caspases-9 and -3 activation in cytosolic extracts
of HL-derived B cells, which is due to high level expression of X-linked inhibitor of apoptosis
(XIAP). Coimmunoprecipitation studies revealed that XIAP, apoptosis protease-activating fac-
tor–1, and caspase-3 are complexed in HL-derived B cell lysates. Even after stimulation with
exogenous cytochrome 
 
c
 
 and dATP, XIAP impairs the proteolytic processing and activation of
caspase-3. In cytosolic extracts, inhibition of XIAP by the second mitochondria-derived activa-
tor of caspases (Smac)/DIABLO, or immunodepletion of XIAP restores cytochrome 
 
c
 
–triggered
processing and activation of caspase-3. Smac or a Smac-derived agonistic peptide also sensitized
intact HL-derived B cells for the apoptotic action of staurosporine. Finally, Hodgkin and
Reed-Sternberg cells of primary tumor HL tissues also constitutively and abundantly express
XIAP. The results of this paper suggest that high level XIAP expression is a hallmark of HL,
which may play a crucial role in resistance to apoptosis.
Key words: cancer • tumor • apoptosis • mitochondria • Smac/DIABLO
 
Introduction
 
At least two distinct major apoptotic signaling pathways
have been identified. The triggering of death domain con-
taining cell surface receptors of the TNF super family results
in the recruitment and activation of the initiator caspase,
caspase-8, followed by a rapid cleavage of caspases-3 and -7,
which in turn cleave vital substrates in the cell (1). The sec-
ond apoptotic signaling pathway involves mitochondria and
results in the release of proapoptotic factors from mito-
chondria, such as cytochrome 
 
c
 
 and the second mitochon-
dria-derived activator of caspases (Smac
 
*
 
; references 2, 3).
Subsequently, the released cytochrome 
 
c
 
, the cytosolic
apoptosis protease-activating factor–1 (Apaf-1), and pro-
caspase-9 form the apoptosome (4). Activation of caspase-9
is induced by dimerization (5) driven by formation of the
multimeric Apaf-1 complex (6). Once activated, caspase-9
can directly process and activate caspases-3 and -7.
Apoptotic pathways converge at the level of caspase-3,
which is expressed in cells as an inactive 32-kD precursor.
The activation of caspase-3 occurs in two steps, beginning
with the initial cleavage by caspase-8 or -9 to form two
subunits. After this cleavage, caspase-3 removes its own
prodomain in two sequential steps, generating the ultimate
p17 active subunit (7).
The activity of the caspases is modulated by another set
of proteins, the inhibitors of apoptosis. One of these, the
X-linked inhibitor of apoptosis (XIAP), binds to and inhib-
its caspases-3, -7, and -9, but not caspase-8 (8). Overex-
pression of XIAP and its family members has been shown
to suppress apoptosis induced by a variety of stimuli, in-
cluding TNF, Fas-L, menadione, staurosporine, etoposide,
taxol, and growth factor withdrawal (9, 10). In the presence
of XIAP, the initial cleavage of procaspase-3 can occur but
not the second autocatalytic cleavage, due to the inhibition
of intrinsic caspase-3 activity (9–11).
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Additional regulation is provided by Smac (3). The pro-
form of Smac contains an NH
 
2
 
-terminal sequence that tar-
gets this protein to the intermembrane space of mitochon-
dria. Upon induction of apoptosis, Smac is released into the
cytosol and modulates apoptosis (3). Smac promotes apop-
tosis by repressing the anticaspase activity of XIAP, thereby
inducing the enzymatic activity of mature caspase-3.
Resistance to apoptotic stimuli is one of the keys to can-
cer cell survival. The malignant Hodgkin and Reed-Stern-
berg (H-RS) cells of Hodgkin’s lymphoma (HL) are germi-
nal center B cells with rearranged but nonproductive
immunoglobulin genes (12). However, through an as yet
unknown mechanism, H-RS cells resist the apoptotic fate
characteristic of defective B cells with crippled immuno-
globulin genes.
In a previous paper, we showed that all tested HL-
derived B cell lines are resistant to staurosporine-induced
cell death and identified a defect in Bax activation (13).
These HL-derived B cell lines are also resistant to CD95-
mediated apoptosis, suggesting that additional defects of the
apoptotic pathway may exist (14). In the present work, we
show that all HL-derived B cell lines have a defect in cas-
pase-3 activation, which is apparently secondary to high
level expression of XIAP.
 
Materials and Methods
 
Cell Culture.
 
The establishment and culturing of the
Hodgkin and control B cell lines have been described previously
(13). Cells were transfected with 0.5 
 
 
 
g Smac NH
 
2
 
-terminal
peptide, H-AVPIAQK-OH, (Calbiochem), Smac protein, or
 
 
 
-galactosidase (119-kD subunit) as a control using the Chariot
protein transfection kit according to the instructions of the manu-
facturer (Active Motif). Apoptosis was induced by 1 
 
 
 
M stauro-
sporine (Qbiogene) and cell death was examined using trypan
blue exclusion.
 
Sample Preparation and Immunoblotting.
 
Whole cell extracts
were prepared by lysing cells in CHAPS lysis buffer (14). Cyto-
solic extracts were prepared in buffer A (20 mM Pipes, pH 7.0,
50 mM KCl, 2 mM MgCl
 
2
 
, 5 mM EGTA, and 1 mM dithiothre-
itol) as described previously (13). Equal amounts (100 
 
 
 
g) of pro-
tein were separated by SDS-PAGE and transferred to nitrocellu-
lose membrane (0.2 
 
 
 
m Protran; Schleicher & Schuell). Rabbit
polyclonal antisera specific for human caspase-3, Apaf-1, human
Bax, and mouse anti-XIAP mAb were obtained from BD Bio-
sciences. Polyclonal antiserum specific for caspase-9 was gener-
ated as described previously (11).
 
Caspase Activation.
 
For initiating caspase activation, either 10
 
 
 
M horse heart cytochrome 
 
c
 
 together with 1 mM dATP or 100
nM of purified recombinant active caspase-8 (15) or 60 
 
 
 
g
granzyme-B (Sigma-Aldrich) were added to 20 
 
 
 
l of cell extracts
or buffer A as a control and incubated for 1 h at 30
 
 
 
C. To deter-
mine the effect of Smac on caspase activation, cytosolic extracts
were incubated with 10 
 
 
 
M horse heart cytochrome 
 
c
 
 together
with 1 mM dATP and 1 
 
 
 
M recombinant Smac protein for 1 h
at 30
 
 
 
C. Reactions were initiated by the addition of 100 
 
 
 
M Ac-
DEVD–7-amino-4-trifluoromethylcomarin (AFC), and caspase
activity was assayed and presented as arbitrary fluorescence units
per minute (FU/min); 1 FU is equivalent to 0.65 pmol released
AFC (13).
 
Immunoprecipitation.
 
Equal amounts (30 
 
 
 
l) of 20 
 
 
 
g/
 
 
 
l cyto-
solic extracts were adjusted to a final volume of 500 
 
 
 
l with
buffer A. Samples were rotated for 6 h at 4
 
 
 
C with 1 
 
 
 
g of mouse
anti–caspase-3 mAb, mouse anti-Bax mAb (BD Biosciences) or
rat anti–Apaf-1 mAb (Chemicon). Antigen–antibody complexes
were immobilized by rotation for 2 h at 4
 
 
 
C with GammaBind-G
Sepharose (Amersham Biosciences). The complexes were centri-
fuged (1 min, 14,000 
 
g
 
 at 4
 
 
 
C) and the supernatant was removed.
After three washes with buffer A, samples were subjected to SDS-
PAGE and immunoblotted as described in Sample Preparation
and Immunoblotting section above.
 
Immunodepletion of XIAP.
 
20 
 
 
 
l (250 
 
 
 
g/ml) mouse anti-
XIAP mAb was added to 100 
 
 
 
l GammaBind-G Sepharose in
500 
 
 
 
l PBS and rotated at 4
 
 
 
C for 3 h. The beads were collected
and the supernatant was removed. The beads were washed once
with 1 ml buffer A and incubated with 300 
 
 
 
l cytosolic extract
(20 
 
 
 
g/
 
 
 
l) for 6 h on a rotator at 4
 
 
 
C. The beads were subse-
quently pelleted and the resulting supernatant was used as XIAP-
immunodepleted cytosolic extract.
 
Expression and Purification of Recombinant Smac Protein.
 
The
cDNA encoding the amino acids 56–239 of Smac was cloned
from a human thymus cDNA library by PCR and cloned into the
Ndel and XhoI sites of the pET-23b vector (Novagen), resulting
in a COOH-terminal His-6–tagged Smac. Expression of recom-
binant Smac was induced with 0.5 mM IPTG for 5 h at 30
 
 
 
C.
The protein was purified on Nichelate sepharose (Amersham
Biosciences) from the soluble fraction of sonicated cells.
 
Immunohistology.
 
Primary tumor tissues from 12 cases of HL
in Danish patients were selected from the archives of the Insti-
tute of Pathology, Aarhus University Hospital. Histological diag-
nosis and subtyping of HL was based on accepted morphological
and immunophenotypical criteria (16). All cases had been exam-
ined for the presence of EBV sequences using EBV-encoded
small RNA (EBER) in situ hybridization. In addition, two ton-
sils and three lymph nodes showing benign reactive lymphoid
hyperplasia were included as controls for immunohistology. All
tissues had been routinely fixed in formalin and embedded in
paraffin. Formalin-fixed and paraffin-embedded tissues were cut
at 4 
 
 
 
m onto silanized slides. Antigen retrieval was performed by
microwave superheating in TEG buffer (10 mM TRIS and 0.5
mM EGTA) at pH 9.0. Sections were incubated with primary
mouse anti-XIAP mAb for 30 min (dilution 1:50). Reactions
were detected using a standard, highly sensitive EnVison™
horseradish peroxidase staining system (DakoCytomation) devel-
oped with diaminobenzidine.
 
Results
 
Failure of Caspase Activation in HL-derived B Cells.
 
HL-
derived B cell lines have been shown to be resistant to
apoptosis induced by CD95 and staurosporine (13, 14). To
investigate if caspases are functional in these cells, we used a
cell-free system and exogenously added cytochrome 
 
c
 
 to
induce proteolytic processing and activation of procaspases-9
and -3 (4, 11). In untreated cell extracts, caspase-9 is de-
tected as its 46-kD proform in all four HL-derived B cell
lines (L1236, L591, L428, and KMH2) and in the control
B cell line L1309 (Fig. 1 A). The addition of cytochrome 
 
c
 
to the cytosolic extracts of L1309 leads to autocatalytical
cleavage of procaspase-9, producing the characteristic p35
fragment. A second cleavage, mediated by subsequently ac-T
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tivated caspase-3, results in the p37 fragment of caspase-9
(17). Concomitantly, the initial p20 fragment and the ulti-
mate p17 subunit of caspase-3 were detected (Fig. 1 B). In
contrast, autocatalytic processing of caspase-9 was impaired
in HL-derived B cell lines, in that only small amounts of
the p35 fragment were generated upon the addition of cy-
tochrome 
 
c
 
 to cytosolic extracts (Fig. 1, A and B). Simi-
larly, caspase-3 processing was not detected. In addition,
cytochrome 
 
c
 
 induced caspase activity in the control B cell
line but not in the HL-derived B cell lines, which indicated
a defective caspase-3 activation cascade (Fig. 1 C).
The examination of proteins involved in caspase-3 acti-
vation downstream of mitochondria showed that the level
of expression of the adaptor protein, Apaf-1, was compara-
ble in all cell lines. In contrast, the antiapoptotic protein
XIAP appeared to be expressed at significantly higher levels
in the HL-derived B cell lines compared with the control B
cell line L1309 (Fig. 2 A).
Moderate or strong immunohistological expression of
XIAP was also seen in H-RS cells in cases of biopsies from
patients suffering HL (Fig. 2 B). Although the two cases of
lymphocytic predominance-HL (Nos. 1 and 2) showed
weak and very weak XIAP staining in their “L and H”
(lymphocytic and histiocytic) Reed-Sternberg variant cells
respectively, the strong staining was seen in both EBV-pos-
itive and EBV-negative classical HL cases. Staining was
predominantly intracytoplasmic, with a striking granularity
(Fig. 2 C). Control tissues and nonneoplastic lymphoid
Figure 1. Failure of cytochrome c to induce caspase activation in cyto-
solic extracts of HL-derived B cell lines. Cytosolic extracts of L1236,
L591, L428, and KMH2 cells, and of control B cell L1309 were prepared
and equal amounts of protein were incubated with or without cyto-
chrome c/dATP for 1 h at 30 C. Cytosolic extracts were resolved by
SDS-PAGE and subjected to Western blot analysis. (A) Procaspase-9
(p46) and its fragments (p37, p35) were detected by polyclonal rabbit
anti–caspase-9 antibody. (B) Procaspase-3 (p32) and its fragments (p20,
p17) were detected by polyclonal anti–caspase-3 antibody. (C) Measure-
ment of relative caspase activity using DEVD-AFC. Samples were nor-
malized for total cytosolic protein content. Asterisk indicates nonspecific
bands recognized by polyclonal antibodies.
Figure 2. Expression of caspase activators and inhibitors in HL-derived
B cell lines. (A) Equal amounts of proteins from total cell lysate of L1236,
L591, L428, and KMH2 cells and of control B cells L1309 were subjected
to SDS-PAGE and Western blot analysis. Proteins were detected using
antibodies against Apaf-1 and XIAP. (B) XIAP expression in primary
Hodgkin’s lymphoma (HL) tissues. XIAP positivity in H-RS cells:    
very weak;      weak;       moderate;        strong staining.
(C) Paraffin section immunohistochemistry of cases 3, 5, 6, 7, 10, and 11
of classical HL cases listed in Fig. 2 B. XIAP was stained using anti-XIAP
specific mAb. There are strong (Nos. 5, 6, 7, and 11) or moderate (Nos. 3
and 10) granular intracytoplasmic staining for XIAP in essentially all mor-
phologically recognizable Hodgkin or Reed-Sternberg cells. Background
lymphocytes are negative for XIAP staining.T
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components within the HL tumors showed mostly no
XIAP staining with few exceptions, where focal weak
staining was observed. However, in some tumors, stronger
staining was detected in background lymphocytes, both
within germinal centers, and in the interfollicular regions
(unpublished data).
 
XIAP Association with Caspase-3 in HL-derived B Cell
Lines.
 
It has been shown previously by Bratton et al. that
XIAP associates with oligomerized Apaf-1, binds processed
caspase-3 produced within the apoptosome, and sequesters
it within the complex (18). To characterize XIAP action in
HL-derived B cells, coimmunoprecipitation studies com-
bined with Western blot analysis were performed (Fig. 3).
In the control B cell line, XIAP did not coimmunoprecipi-
tate with caspase-3 in activated lysates upon the addition of
dATP/cytochrome 
 
c
 
, and caspase-3 was fully processed to
form the enzymatically active p17 fragment, which is con-
sistent with previous papers. In contrast, XIAP coimmuno-
precipitated with caspase-3 in lysates from HL-derived B
cells. Upon addition of cytochrome 
 
c
 
, caspase-3 was only
partially processed to form the p24–20 fragments and failed
to remove its own prodomain, which can be sensed as a
“footprint” for XIAP-mediated inhibition of caspase-3
(Fig. 3 B; reference 11). The incomplete processing of cas-
pase-3 was accompanied by partial cleavage of XIAP,
which led to formation of a p48 XIAP fragment. Both in-
tact XIAP and the p48 fragments remained associated with
caspase-3 in activated extracts of HL-derived B cells. The
coimmunoprecipitation of Apaf-1 with caspase-3 demon-
strated the efficient formation of apoptosome complexes in
all cell lines after cytochrome 
 
c
 
 addition.
XIAP, Apaf-1, and caspase-3 also coimmunoprecipitated
in unactivated lysates of HL-derived B cell lines (Fig. 3, B
and C), indicating the preformation of XIAP–apoptosome
complexes. In these lysates, XIAP did not coimmunopre-
cipitate with Bax (Fig. 3 D), which excludes immunopre-
cipitation conditions favoring nonspecific binding.
 
Caspase-8 and Granzyme-B Partially Bypass the XIAP-
mediated Inhibition of Caspase-3 in HL-derived B Cell Lines.
 
Caspase-3 is not only activated within the apoptosome
but alternatively by caspase-8 and granzyme-B (19, 20).
To determine whether XIAP action in HL-derived B
cells extends to caspase-3 activation outside the apopto-
some, recombinant active caspase-8 or granzyme-B were
added to the cytosolic extracts of HL-derived B cells. As
shown in Fig. 4, both of these proteases cleaved caspase-3,
which resulted in the p20 fragment, characteristic of the
initial cleavage of caspase-3 (19, 20). Notably, the auto-
catalytic maturation generating the p17 fragment pro-
ceeded to a lesser degree in the cytosolic extracts of HL-
derived B cell lines compared with the control B cell line.
We conclude that in HL-derived B cells, XIAP does not
prevent the initial cleavage of caspase-3 induced by cas-
pase-8 or granzyme-B, but rather inhibits the subsequent
autocatalytic processing to the mature p17 fragment.
Incomplete caspase-3 processing corresponds with de-
creased caspase-3 activity in HL-derived B cell extracts
(Fig. 4).
 
Physical or Functional Depletion of XIAP Restores Cyto-
chrome c–induced Caspase-3 Activity in HL-derived B Cells.
 
If XIAP was the key inhibitor of apoptosis in HL-derived
Figure 3. XIAP coimmunoprecipitates with activated caspase-3. Cyto-
solic extracts of L1236, L591, L428, and KMH2 cells and of control B
cells L1309 were prepared, and equal amounts of protein were incubated
with or without cytochrome c/dATP for 1 h at 30 C. (A) 100  g samples
were resolved by SDS-PAGE and subjected to Western blot analysis.
XIAP was detected by mouse anti-XIAP mAb. (B–D) Caspase-3, Apaf-1,
and Bax were immunoprecipitated by mouse anti–caspase-3, rat anti–
Apaf-1, and mouse anti-Bax mAb in 600- g cytosolic extracts and sub-
jected to SDS-PAGE and Western blotting. XIAP, caspase-3, Apaf-1, and
Bax were detected by mouse anti-XIAP mAb, polyclonal rabbit anti–cas-
pase-3, polyclonal rabbit anti–Apaf-1, and polyclonal rabbit anti-Bax anti-
bodies. Asterisk indicates mouse IgG.T
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B cells, removal of XIAP should relieve the inhibition of
caspase-3 activation. Indeed, in the presence of Smac, a mi-
tochondrial inhibitor of XIAP, the ability of cytochrome 
 
c
 
was restored to trigger processing and activation of caspase-3
in HL-derived B cells (Fig. 5, A and B). In addition, im-
munodepletion of XIAP using a mouse mAb anti-XIAP
antibody resulted in an enhancement of caspase-3 activity
(Fig. 5 C), providing further evidence for a central role of
XIAP in inhibition of caspase-3 activation in HL-derived B
cells. Finally, transfection of intact HL-derived B cells with
Smac or a Smac agonistic peptide sensitized these cells for
the proapoptotic activity of staurosporine (Fig. 5 D), con-
firming that high level expression of XIAP constitutes a
state of apoptotic resistance in HL.
 
Discussion
 
Primary H-RS cells and HL-derived B cell lines have
been shown to be resistant to different apoptotic stimuli
(13, 14). We show here that XIAP, a potent inhibitor of
caspase-3, is expressed constitutively and at high levels in
HL-derived B cells as well as in H-RS cells of tumor biop-
sies. Correspondingly, cytochrome 
 
c
 
, as well as caspase-8–
or granzyme-B–induced activation of caspase-3 is severely
impaired in lysates of HL-derived B cell lines. Functional
neutralization of XIAP by Smac restored the apoptotic re-
sponse in lysates as well as in intact HL-derived B cells,
suggesting that XIAP is a main mediator of apoptotic resis-
tance in HL.
Upon the addition of cytochrome 
 
c
 
, caspase-9 is
thought to be activated without cleavage (18, 21), and ul-
timately processed by an autocatalytic mechanism generat-
ing a p35 fragment (4). It has been suggested that the pro-
cessing of caspase-9 to p35 is the signal for inhibition by
XIAP, due to the unmasking of a neoepitope in the small
subunit (17). Thus, XIAP may also inhibit the unprocessed
form of caspase-9, as described previously (11). The in-
complete caspase-9 processing in cytochrome 
 
c
 
–treated cy-
tosolic extracts of HL-derived B cells (Fig. 1 A) is fully
consistent with the mechanism described for XIAP-medi-
ated caspase-9 inhibition.
Our finding that XIAP is coimmunoprecipitated with
both caspase-3 and Apaf-1 in lysates of HL-derived B cells
deserves consideration. With regard to the formation of ap-
optosomes, the sequence of events has been established
previously. Accordingly, XIAP does not bind to Apaf-1
apoptosome in unactivated lysates but does so after cyto-
chrome 
 
c
 
–triggered oligomerization of Apaf-1 (18). Within
the apoptosome, XIAP binds to caspases-9 and -3 simulta-
neously (18). However, XIAP does not bind to unactivated
caspase-3. The coimmunoprecipitation of XIAP with cas-
pase-3 in the apparent absence of caspase-3 processing (Fig.
3 B) could be of an indirect nature because of XIAP associ-
ation with Apaf-1 (Fig. 3 C), which in turn associates with
both processed and unprocessed caspase-3 (18). The copre-
cipitation of XIAP, Apaf-1, and caspase-3 in untreated cy-
tosolic extracts of HL-derived B cells raises the question
whether high-level expression of XIAP leads to spontane-
ous association with Apaf-1 apoptosome. However, only
little if any association of XIAP with caspase-3 has been
observed in unactivated lysates (18). Alternatively, very low
amounts of cytochrome 
 
c
 
, accidently released during the
preparation of cytosolic extracts, could have induced the
formation of Apaf-1 apoptosome–XIAP complexes, which
Figure 4. Caspase-3 activation by caspase-8 and granzyme-B. Cytosolic
extracts of L1236, L591, L428, and KMH2 cells and of control B cells
L1309 were prepared, and equal amounts of protein were left untreated or
incubated for 1 h with recombinant active caspase-8 (A) and granzyme-B
(B) at 30 C. Cytosolic extracts were resolved by SDS-PAGE and subjected
to Western blot analysis. Caspase-3 and XIAP were detected by polyclonal
rabbit anti–caspase-3 antibody and mouse anti-XIAP mAb. Relative cas-
pase activity was measured using DEVD-AFC after incubation of cytosolic
extracts with recombinant active caspase-8 (A)and granzyme-B (B). Sam-
ples were normalized for total cytosolic protein content.T
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tracts of HL-derived B cells, caspase-8 and granzyme-B
induced protease activity of caspase-3, although at re-
duced levels. This is due to the initial cleavage of caspase-3
into large and small subunits, whereas autocatalytic pro-
cessing is apparently inhibited by XIAP (8, 11, 20). In
contrast to caspase-8 and granzyme-B, caspase-9–induced
caspase-3 activation was nearly completely abrogated (Fig.
1, B and C).
Overexpression of XIAP has been shown to effectively
inhibit a variety of cell death programs (9–10, 22). These
observations suggest that XIAP may play a key role in the
regulation of apoptosis in cancer cells, such as human mela-
noma (22). The XIAP gene can be up-regulated by NF-
 
 
 
B
(23). Constitutive activation of NF-
 
 
 
B appeared to be an
unique feature of H-RS cells, which has been suggested
previously to play an important role in the pathogenesis of
H-RS cells (24). The overexpression of XIAP, a target
gene for NF-
 
 
 
B, is in line with these observations and pro-
vides a plausible link for NF-
 
 
 
B–mediated resistance to
apoptosis in HL-derived B cells. The finding that Smac or
Smac agonistic peptides sensitize HL-derived B cells for
staurosporine-induced apoptosis may have clinical implica-
tions. Further work will be required to determine whether
neutralization of XIAP can be developed into a novel mo-
dality to sensitize HL cells for chemotherapeutic agents.
HL is unusual among neoplasms in that the malignant
H-RS cells are typically rare in the affected tissues. This has
hampered research into the pathogenesis of the disease for
many years. The use of HL-derived B cell lines has helped
many investigators to analyze this tumor at the molecular
level. Our observation that XIAP is consistently overex-
pressed in H-RS cells of primary HL tumors provides an-
other example, suggesting that molecular mechanisms de-
fined in HL B cell lines may hold true for HL tumor cells
in vivo.
 
We thank K. Krönke-Wiegmann for excellent technical assistance. 
This work was supported by the Deutsche Krebshilfe (to M.
Krönke), Deutsche Forschungsgemeinschaft (to M. Krönke and
J.M. Jürgensmeier), the National Institutes of Health (grant
AG15402 to G.S. Salvesen), and Köln Fortune (to J.M.
Jürgensmeier).
 
are particularly detectable in XIAP-overexpressing cells. In
this context, it is important to note that Apaf-1, caspases-9,
and -3 were expressed at the same levels and that neither
caspase-3 and nor XIAP revealed mutations in the primary
structure (unpublished data).
As an executioner caspase, caspase-3 represents a target
of converging caspase cascades including caspase-8, cas-
pase-9, and granzyme-B. When added to cytosolic ex-
 
Figure 5.
 
Depletion of XIAP restores caspase-3 processing and activity.
Cytosolic extracts of L1236 and KMH2 cells and of control B cell L1309
were prepared, and equal amounts of protein were incubated with or
without cytochrome 
 
c
 
/dATP in the absence and presence of Smac pro-
tein for 1 h at 30
 
 
 
C. (A) Cytosolic extracts were resolved by SDS-PAGE
and subjected to Western blot analysis. Caspase-3 was detected by poly-
clonal rabbit anti–caspase-3 antibody. (B) Relative caspase activity was
measured by hydrolysis of DEVD-AFC. Samples were normalized for to-
tal cytosolic protein content. (C) XIAP was immunodepleted by mouse
anti-XIAP mAb. Cytosolic extracts of KMH2 cells with or without XIAP
were incubated with or without cytochrome c/dATP for 1 h at 30 C.
Samples were normalized for total cytosolic protein content and relative
caspase-3 activity was measured by DEVDase activity. (D) Cells were
transfected with vehicle,  -galactosidase, Smac N7 peptide, or Smac
protein and treated for 24 h with 1  M staurosporine. Cell death was
determined by trypan blue exclusion. Each value represents the average
of results from two independent experiments.T
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